Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    July 2021
  1. KELLEY RK, Greten TF
    Hepatocellular Carcinoma - Origins and Outcomes.
    N Engl J Med. 2021;385:280-282.
    PubMed    


  2. BUTTERS CT, Nash M
    Infantile Hepatic Hemangiomas.
    N Engl J Med. 2021;385:e10.
    PubMed    


  3. NEWSOME PN, Sejling AS, Sanyal AJ
    Semaglutide or Placebo for Nonalcoholic Steatohepatitis. Reply.
    N Engl J Med. 2021;385:e6.
    PubMed    


  4. DA BL, Satapathy SK
    Semaglutide or Placebo for Nonalcoholic Steatohepatitis.
    N Engl J Med. 2021;385:e6.
    PubMed    


    June 2021
  5. BAJAJ JS, Kamath PS, Reddy KR
    The Evolving Challenge of Infections in Cirrhosis.
    N Engl J Med. 2021;384:2317-2330.
    PubMed    


  6. WONG F, Curry MP, Sanyal AJ
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    PubMed    


  7. CHINA L, Freemantle N, O'Brien A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    PubMed    


  8. RATHI S, Kalantri A, Kalantri S
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed    


  9. CHAUHAN A, Sharma S, Saraya A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed    


  10. ELFEKI MA, O'Shea R, Carey WD
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed    


    April 2021
  11. COHN A, Nehs M, Chan J, Vaidya A, et al
    Casting a Wide Net.
    N Engl J Med. 2021;384:e50.
    PubMed    


  12. MCINNES IB, Anderson JK, Magrey M, Merola JF, et al
    Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.
    N Engl J Med. 2021;384:1227-1239.
    PubMed     Abstract available


    March 2021
  13. GOYAL L, Chen CT, Pierce TT, Deshpande V, et al
    Case 8-2021: A 34-Year-Old Woman with Cholangiocarcinoma.
    N Engl J Med. 2021;384:1054-1064.
    PubMed    


  14. GARCIA-TSAO G
    Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe.
    N Engl J Med. 2021;384:869-871.
    PubMed    


  15. WONG F, Pappas SC, Curry MP, Reddy KR, et al
    Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
    N Engl J Med. 2021;384:818-828.
    PubMed     Abstract available


  16. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:808-817.
    PubMed     Abstract available


    November 2020
  17. NEWSOME PN, Buchholtz K, Cusi K, Linder M, et al
    A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028395.
    PubMed     Abstract available


  18. BALWANI M, Sardh E, Gouya L
    Givosiran for Acute Intermittent Porphyria. Reply.
    N Engl J Med. 2020;383:1989-1990.
    PubMed    


  19. GOMA-GARCES E, Perez-Gomez MV, Ortiz A
    Givosiran for Acute Intermittent Porphyria.
    N Engl J Med. 2020;383:1989.
    PubMed    


    August 2020
  20. JALAN R, Moreau R, Arroyo V
    Acute-on-Chronic Liver Failure. Reply.
    N Engl J Med. 2020;383:893-894.
    PubMed    


  21. PERRICONE G, Mancuso A, Belli LS
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;383:893.
    PubMed    


  22. KUMAR K, Kulkarni A
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;383:892-893.
    PubMed    


  23. JINDAL A
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;383:892.
    PubMed    


  24. FINN RS, Cheng AL
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply.
    N Engl J Med. 2020;383:695.
    PubMed    


  25. TARANTINO P, Curigliano G
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
    N Engl J Med. 2020;383:694-695.
    PubMed    


  26. HIZAL M, Sendur MAN, Yalcin B
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
    N Engl J Med. 2020;383:694.
    PubMed    


  27. BOMZE D, Meirson T, Azoulay D
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
    N Engl J Med. 2020;383:693-694.
    PubMed    


    July 2020
  28. SHEHADEH M, Oweis E
    Silver Stool.
    N Engl J Med. 2020;383:261.
    PubMed    


    June 2020
  29. SIMON TG, Ludvigsson JF
    Association between Aspirin and Hepatocellular Carcinoma. Reply.
    N Engl J Med. 2020;382:2481-2482.
    PubMed    


  30. CAREY W, Romero-Marrero C
    Association between Aspirin and Hepatocellular Carcinoma.
    N Engl J Med. 2020;382:2481.
    PubMed    


  31. LIAO R, Zhou BY, Wu ZJ
    Association between Aspirin and Hepatocellular Carcinoma.
    N Engl J Med. 2020;382:2480-2481.
    PubMed    


  32. GONZALEZ-ASEGUINOLAZA G
    Givosiran - Running RNA Interference to Fight Porphyria Attacks.
    N Engl J Med. 2020;382:2366-2367.
    PubMed    


  33. BALWANI M, Sardh E, Ventura P, Peiro PA, et al
    Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
    N Engl J Med. 2020;382:2289-2301.
    PubMed     Abstract available


    May 2020
  34. ARROYO V, Moreau R, Jalan R
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;382:2137-2145.
    PubMed    


  35. FINN RS, Qin S, Ikeda M, Galle PR, et al
    Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
    N Engl J Med. 2020;382:1894-1905.
    PubMed     Abstract available


  36. KELLEY RK
    Atezolizumab plus Bevacizumab - A Landmark in Liver Cancer.
    N Engl J Med. 2020;382:1953-1955.
    PubMed    


  37. MICIC D, Oto A, Charlton MR, Benoit JL, et al
    Hiding in the Water.
    N Engl J Med. 2020;382:1844-1849.
    PubMed    


    April 2020
  38. MCELVANEY OJ, Carroll TP, Franciosi AN, Sweeney J, et al
    Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy.
    N Engl J Med. 2020;382:1478-1480.
    PubMed    


  39. STRNAD P, McElvaney NG, Lomas DA
    Alpha1-Antitrypsin Deficiency.
    N Engl J Med. 2020;382:1443-1455.
    PubMed    


  40. LAU JYW, Yu Y, Tang RSY, Chan HCH, et al
    Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding.
    N Engl J Med. 2020;382:1299-1308.
    PubMed     Abstract available


    March 2020
  41. SIMON TG, Duberg AS, Aleman S, Chung RT, et al
    Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.
    N Engl J Med. 2020;382:1018-1028.
    PubMed     Abstract available


  42. KUMAR P, Rao PN
    Hepatopulmonary Syndrome.
    N Engl J Med. 2020;382:e14.
    PubMed    


    February 2020
  43. WANG K, Wu S
    Biliary Cast Syndrome.
    N Engl J Med. 2020;382:e13.
    PubMed    


    January 2020
  44. ROSSI UG, Cariati M
    Intrahepatic Biliary Ductal Dilatation.
    N Engl J Med. 2020;382:364.
    PubMed    


    November 2019
  45. DEFILIPP Z, Bloom PP, Torres Soto M, Mansour MK, et al
    Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant.
    N Engl J Med. 2019;381:2043-2050.
    PubMed     Abstract available


  46. SAMUEL VT, Shulman GI
    Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides.
    N Engl J Med. 2019;381:1866-1869.
    PubMed    


  47. KWOK J, Buxbaum JL
    Liver Fluke.
    N Engl J Med. 2019;381:e34.
    PubMed    


    October 2019
  48. HOOFNAGLE JH, Bjornsson ES
    Drug-Induced Liver Injury - Types and Phenotypes. Reply.
    N Engl J Med. 2019;381:1396.
    PubMed    


  49. GABBI C, Bertolotti M
    Drug-Induced Liver Injury - Types and Phenotypes.
    N Engl J Med. 2019;381:1395-1396.
    PubMed    


  50. RATHI S, Kumar P
    Drug-Induced Liver Injury - Types and Phenotypes.
    N Engl J Med. 2019;381:1395.
    PubMed    


    July 2019
  51. MASSOLO A, Klein C, Kowalewska-Grochowska K, Belga S, et al
    European Echinococcus multilocularis Identified in Patients in Canada.
    N Engl J Med. 2019;381:384-385.
    PubMed    


  52. HOOFNAGLE JH, Bjornsson ES
    Drug-Induced Liver Injury - Types and Phenotypes.
    N Engl J Med. 2019;381:264-273.
    PubMed    


  53. VILLANUEVA A
    Hepatocellular Carcinoma. Reply.
    N Engl J Med. 2019;381:e2.
    PubMed    


  54. DURAN SR, Jaquiss RDB
    Hepatocellular Carcinoma.
    N Engl J Med. 2019;381:e2.
    PubMed    


  55. KIM YS, Shin SW
    Hepatocellular Carcinoma.
    N Engl J Med. 2019;381:e2.
    PubMed    


    June 2019
  56. FOURNIER JB, Testa EJ
    Nonbacterial Thrombotic Endocarditis.
    N Engl J Med. 2019;380:e48.
    PubMed    


    May 2019
  57. ADIN ME
    Liver Involvement in Autosomal Dominant Polycystic Kidney Disease.
    N Engl J Med. 2019;380:1954.
    PubMed    


  58. APELLANIZ-RUIZ M, Segni M, Kettwig M, Gluer S, et al
    Mesenchymal Hamartoma of the Liver and DICER1 Syndrome.
    N Engl J Med. 2019;380:1834-1842.
    PubMed     Abstract available


    April 2019
  59. VILLANUEVA A
    Hepatocellular Carcinoma.
    N Engl J Med. 2019;380:1450-1462.
    PubMed    


    February 2019
  60. ROMEO S
    Notch and Nonalcoholic Fatty Liver and Fibrosis.
    N Engl J Med. 2019;380:681-683.
    PubMed    


  61. SARDH E, Harper P, Balwani M, Stein P, et al
    Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
    N Engl J Med. 2019;380:549-558.
    PubMed     Abstract available


    December 2018
  62. FUSTER D, Samet JH
    Alcohol Use in Patients with Chronic Liver Disease.
    N Engl J Med. 2018;379:2579.
    PubMed    


  63. RATHI S, Singh A, Singh V
    Alcohol Use in Patients with Chronic Liver Disease.
    N Engl J Med. 2018;379:2578-2579.
    PubMed    


  64. CAPUTO F, Zoli G, Bernardi M
    Alcohol Use in Patients with Chronic Liver Disease.
    N Engl J Med. 2018;379:2577-2578.
    PubMed    


  65. WANG HH, Lin WR
    Amebic Liver Abscess.
    N Engl J Med. 2018;379:2255.
    PubMed    


    November 2018
  66. PATIL T, Pacheco JM
    Miliary Metastases in Non-Small-Cell Lung Cancer.
    N Engl J Med. 2018;379:1945.
    PubMed    


  67. KOZLITINA J, Stender S, Hobbs HH, Cohen JC, et al
    HSD17B13 and Chronic Liver Disease in Blacks and Hispanics.
    N Engl J Med. 2018;379:1876-1877.
    PubMed    


    October 2018
  68. MURPHY JE, Shampain K, Riley LE, Clark JW, et al
    Case 32-2018: A 36-Year-Old Pregnant Woman with Newly Diagnosed Adenocarcinoma.
    N Engl J Med. 2018;379:1562-1570.
    PubMed    


  69. CAULLEY L
    A Seat at the Table.
    N Engl J Med. 2018;379:1400-1401.
    PubMed    



  70. Cabozantinib in Hepatocellular Carcinoma.
    N Engl J Med. 2018;379:1384-1385.
    PubMed    


  71. MAEDA O, Ando Y
    Cabozantinib in Hepatocellular Carcinoma.
    N Engl J Med. 2018;379:1384.
    PubMed    


    September 2018
  72. CALDERARO J, Letouze E, Bayard Q, Boulai A, et al
    Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma.
    N Engl J Med. 2018;379:1178-1180.
    PubMed    



  73. Bezafibrate in Primary Biliary Cholangitis.
    N Engl J Med. 2018;379:984-985.
    PubMed    


  74. JONES DE, Hegade VS
    Bezafibrate in Primary Biliary Cholangitis.
    N Engl J Med. 2018;379:984.
    PubMed    


    August 2018
  75. SCHRAMM C
    Bile Acids, the Microbiome, Immunity, and Liver Tumors.
    N Engl J Med. 2018;379:888-890.
    PubMed    


  76. KEYSERLING K, Koprowski S
    Spur-Cell Anemia.
    N Engl J Med. 2018;379:774.
    PubMed    


    July 2018
  77. LEMBARKI G, El Benna N
    Echinococcal Cysts in the Liver.
    N Engl J Med. 2018;379:181.
    PubMed    


  78. ABOU-ALFA GK, Meyer T, Cheng AL, El-Khoueiry AB, et al
    Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
    N Engl J Med. 2018;379:54-63.
    PubMed     Abstract available


    June 2018
  79. BROCK PR, Maibach R, Childs M, Rajput K, et al
    Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
    N Engl J Med. 2018;378:2376-2385.
    PubMed     Abstract available


  80. CAREY EJ
    Progress in Primary Biliary Cholangitis.
    N Engl J Med. 2018;378:2234-2235.
    PubMed    


  81. CORPECHOT C, Chazouilleres O, Rousseau A, Le Gruyer A, et al
    A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
    N Engl J Med. 2018;378:2171-2181.
    PubMed     Abstract available


    May 2018
  82. KOEHLER VF, Parhofer KG
    Xanthoma Striatum Palmare.
    N Engl J Med. 2018;378:e26.
    PubMed    


  83. SLACK FJ
    Tackling Tumors with Small RNAs Derived from Transfer RNA.
    N Engl J Med. 2018;378:1842-1843.
    PubMed    


    March 2018
  84. ABUL-HUSN NS, Cheng X, Li AH, Xin Y, et al
    A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.
    N Engl J Med. 2018;378:1096-1106.
    PubMed     Abstract available


  85. WINNER S
    Tumors and Transformations.
    N Engl J Med. 2018;378:887-889.
    PubMed    


    February 2018

  86. Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:779-781.
    PubMed    


  87. RAHMOUNE H, Boutrid N, Bioud B
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:780-1.
    PubMed    


  88. SACHAK T, Yearsley M, Levin D
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:780.
    PubMed    


  89. ASHRAFIAN H
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:780.
    PubMed    


  90. YILDIZ H
    Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:779-80.
    PubMed    


  91. BALTIMORE RS, Nimkin K, Sparger KA, Pierce VM, et al
    Case 4-2018: A Newborn with Thrombocytopenia, Cataracts, and Hepatosplenomegaly.
    N Engl J Med. 2018;378:564-572.
    PubMed    


    January 2018
  92. ATRI D, Furfaro D, Dhaliwal G, Feingold KR, et al
    Going from A to Z.
    N Engl J Med. 2018;378:73-79.
    PubMed    


    December 2017

  93. Use of Liver Imaging and Biopsy in Clinical Practice.
    N Engl J Med. 2017;377:2295-2297.
    PubMed    


    November 2017
  94. DIEHL AM, Day C
    Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
    N Engl J Med. 2017;377:2063-2072.
    PubMed    


  95. JARAMILLO-CALLE DA
    Porphyria.
    N Engl J Med. 2017;377:2100-1.
    PubMed    


  96. SOOD S, Mingos N, Ross G
    Porphyria.
    N Engl J Med. 2017;377:2100.
    PubMed    


  97. BISSELL DM, Anderson KE, Bonkovsky HL
    Porphyria.
    N Engl J Med. 2017;377:2101.
    PubMed    


  98. RENCIC J, Zhou M, Hsu G, Dhaliwal G, et al
    Circling Back for the Diagnosis.
    N Engl J Med. 2017;377:1778-1784.
    PubMed    


  99. MENDELL JR, Al-Zaidy S, Shell R, Arnold WD, et al
    Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.
    N Engl J Med. 2017;377:1713-1722.
    PubMed     Abstract available


    August 2017
  100. BISSELL DM, Anderson KE, Bonkovsky HL
    Porphyria.
    N Engl J Med. 2017;377:862-872.
    PubMed    


  101. TAPPER EB, Lok AS
    Use of Liver Imaging and Biopsy in Clinical Practice.
    N Engl J Med. 2017;377:756-768.
    PubMed    


    July 2017
  102. CHEN YY, Chen CC
    Cholelithiasis.
    N Engl J Med. 2017;377:371.
    PubMed    


    March 2017
  103. HUANG CS
    Fournier's Gangrene.
    N Engl J Med. 2017;376:1158.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: